USPTO Examiner HOFFPAUIR ANDREW ELI - Art Unit 3791

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19203945AI-Assisted Raman Spectroscopy System for Biomarker Analysis of Aqueous HumorMay 2025November 2025Allow621YesNo
19176058TEMPERATURE SELF-COMPENSATION INTERVENTIONAL OPTICAL FIBER PRESSURE GUIDEWIRE AND WIRELESS FFR MONITORApril 2025December 2025Allow820YesNo
18850666AUTOMATIC DETECTION SYSTEM AND DEVICE FOR CAPTURING ICTAL SEMIOLOGY OF EPILEPTIC PATIENTSeptember 2024February 2026Abandon1620NoNo
18679796DEVICE FOR PROCESSING AND VISUALIZING DATA OF AN ELECTRIC IMPEDANCE TOMOGRAPHY APPARATUS FOR DETERMINING AND VISUALIZING REGIONAL VENTILATION DELAYS IN THE LUNGSMay 2024October 2025Allow1620YesYes
17917082A METHOD AND A SYSTEM FOR DETECTING AND OVERCOMING A DEVIATING GAITOctober 2022January 2026Abandon4010NoNo
17952260METHOD AND SYSTEM FOR SUPPORTING MOTHERS OF NEWBORN INFANTS DURING BREASTFEEDINGSeptember 2022October 2025Abandon3610NoNo
17873051TOOTH ANALYSIS SERVER, TOOTH ANALYSIS TERMINAL, AND TOOTH ANALYSIS PROGRAMJuly 2022January 2026Abandon4210NoNo
17832472DEVICE AND METHOD FOR LOCATING TARGET CEREBRAL POINTS IN MAGNETIC RESONANCE IMAGESJune 2022December 2025Abandon4201NoNo
17636478BIOLOGICAL SAMPLE COLLECTION DEVICE AND METHOD OF USING SAMEFebruary 2022November 2025Abandon4501NoNo
17625907SYSTEMS AND METHODS FOR DETECTING COGNITIVE DECLINE WITH MOBILE DEVICESJanuary 2022July 2025Abandon4301NoNo
17625318METHOD FOR STABILIZING CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMJanuary 2022February 2026Abandon4920NoNo
17646078METHOD FOR CHARACTERIZING BLOOD PRESSUREDecember 2021October 2025Abandon4611NoNo
17620772BIOMEDICAL ELECTRODE, BIOMEDICAL SENSOR, AND BIOMEDICAL SIGNAL MEASUREMENT SYSTEMDecember 2021December 2025Abandon4720NoNo
17533596BLOOD PRESSURE MEASUREMENT SYSTEMS AND METHODSNovember 2021November 2025Abandon4820NoNo
17595234SYSTEMS AND METHODS FOR ACCESSING A RENAL CAPSULE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSESNovember 2021October 2025Allow4730YesNo
17595070FINGER CLIP TYPE OXIMETRY DEVICE ADAPTIVE TO THICK AND THIN FINGERSNovember 2021April 2025Allow4120NoNo
17606485HEART RATE SENSOR AND ELECTRONIC DEVICE FOR COLLECTING HEART RATEOctober 2021October 2025Abandon4720NoNo
17505527WOUND MEASUREMENTOctober 2021February 2025Abandon4010NoNo
17450697METHOD AND SYSTEM FOR PERSONALIZED EYE BLINK DETECTIONOctober 2021August 2025Abandon4640YesNo
17600388BIOLOGICAL SAMPLE CAPTURING DEVICESeptember 2021October 2025Abandon4920NoNo
17441858METHOD AND DEVICE FOR MEASURING OR DETERMINING AT LEAST ONE BIOMECHANICAL PARAMETER OF SOFT BIOLOGICAL TISSUESSeptember 2021August 2025Allow4621NoNo
17441836MICRONEEDLE PATCH, REALTIME BLOOD SUGAR MONITORING DEVICE, AND REALTIME BLOOD SUGAR MONITORING METHOD USING SAMESeptember 2021February 2025Abandon4110NoNo
17441364BLOOD VOLUME PULSE SIGNAL DETECTION APPARATUS, BLOOD VOLUME PULSE SIGNAL DETECTION APPARATUS METHOD, AND COMPUTER-READABLE STORAGE MEDIUMSeptember 2021October 2025Abandon4820YesNo
17441055A SWEAT SENSING SYSTEMSeptember 2021April 2025Allow4320NoYes
17409177BIOMARKER MONITORING SENSOR AND METHODS OF USEAugust 2021April 2025Allow4321YesNo
17426332MEDICAL DEVICE WITH MISALIGNED CANNULAJuly 2021August 2025Abandon4920NoNo
17443405FEMALE URINE COLLECTION AND DRAINAGE DEVICE AND METHODS OF USE THEREOFJuly 2021November 2024Allow4010YesNo
17385046FOREHEAD TEMPERATURE MEASUREMENT SYSTEM WITH HIGH ACCURACYJuly 2021December 2025Allow5350YesYes
17423420EXTENSION CATHETER AND METHOD FOR PRODUCING SAMEJuly 2021May 2025Abandon4620NoNo
17421260DEVICE FOR VENOUS-PRESSURE SENSINGJuly 2021March 2025Allow4420YesYes
17369099DERMAL IMAGE CAPTUREJuly 2021August 2025Allow4930NoNo
17420636SPORTS PAD WITH FORCE SENSORSJuly 2021May 2025Abandon4620NoNo
17360512CHILDBIRTH AND LABOR MONITORING METHOD AND SYSTEMJune 2021April 2025Abandon4620NoNo
17348714HYBRID BODY TEMPERATURE MEASUREMENT SYSTEM AND METHOD THEREOFJune 2021September 2024Allow3930NoNo
17347582ORTHOSTATIC REPORTING ASSEMBLY, ORTHOSTATIC REPORTING SYSTEM, AND RELATED METHOD OF USEJune 2021September 2025Abandon5121YesNo
17345500COLLECTION OF CELLS FROM BIOLOGICAL FLUIDJune 2021February 2025Abandon4420YesNo
17413098MONITOR SYSTEM OF MULTIPLE PARKINSON'S DISEASE SYMPTOMS AND THEIR INTENSITYJune 2021July 2025Allow4930YesNo
17335417PULSE DETECTION APPARATUS AND PULSE DETECTION METHODJune 2021November 2024Abandon4220NoNo
17294617SELF-MONITORING AND CARE ASSISTANT FOR ACHIEVING GLYCEMIC GOALSMay 2021December 2024Abandon4310NoNo
17307562TRANSPARENT FACE MASK WITH OPTIONAL TEMPERATURE MONITORING DEVICE AND OPTIONAL DETACHABLE EYE PROTECTIONMay 2021October 2024Abandon4210NoNo
17306708SYSTEM AND DEVICE FOR WATERJET NECROSECTOMYMay 2021October 2024Abandon4110NoNo
17284053Digital EndoscopeApril 2021July 2025Allow5130YesNo
17282226DEVICE FOR COLLECTING POLYPSApril 2021January 2025Abandon4520NoNo
17214157SYSTEMS AND METHODS FOR DEPOSITING MATERIAL IN A PATIENTMarch 2021April 2025Abandon4820NoNo
17199558STICKING-TYPE CORE BODY THERMOMETERMarch 2021July 2024Allow4010NoNo
17275701BREATH SAMPLERMarch 2021March 2025Allow4830NoNo
17189537PATIENT BODY MONITORING USING RADARMarch 2021April 2024Allow3720NoNo
17271810BIRTH DELIVERY MAGNETIC TRACKING SYSTEMFebruary 2021June 2025Abandon5230NoNo
17271282BLOOD PRESSURE MEASUREMENT DEVICE, VEHICLE DEVICE, AND BLOOD PRESSURE MEASUREMENT PROGRAMFebruary 2021June 2024Abandon4010NoNo
17270677A Sleep Monitoring System For Monitoring And Measuring Sleeping ActivityFebruary 2021August 2025Abandon5430NoNo
17269067SYSTEM AND METHOD FOR PROVIDING AN INDICATION OF A PERSON'S GUM HEALTHFebruary 2021April 2025Allow5031YesNo
17165285SENSOR UNIT AND BED APPARATUSFebruary 2021July 2024Abandon4210NoNo
17156277SYSTEMS AND METHODS TO PROVIDE A PHYSICIAN INTERFACE THAT ENABLES A PHYSICIAN TO ASSESS ASTHMA OF A SUBJECT AND PROVIDE THERAPEUTIC FEEDBACKJanuary 2021November 2024Abandon4620NoNo
17154870SYSTEMS AND METHODS FOR ELECTROMYOMETRIAL IMAGINGJanuary 2021May 2024Allow4021NoNo
17146966BIOMETRIC DATA MEASUREMENT SYSTEM AND BIOMETRIC DATA MEASUREMENT METHODJanuary 2021August 2024Allow4320YesNo
17147185Impairment Detection Method and DevicesJanuary 2021May 2024Abandon4010NoNo
17251618APPARATUS FOR SENSINGDecember 2020January 2026Abandon6040NoNo
17114200OCULAR MICRO TREMOR (OMT) SENSOR, SYSTEM AND METHODDecember 2020February 2025Allow5130YesNo
16972137SAMPLE REMOVAL ASSEMBLY FOR GYNECOLOGICAL EXAMINATIONSDecember 2020May 2024Abandon4110NoNo
16950258APPARATUS AND METHOD FOR ESTIMATING BIO-INFORMATIONNovember 2020May 2025Abandon5430YesNo
17054804BODY SENSORNovember 2020January 2025Abandon5120NoNo
17048454COMPONENT CONCENTRATION MEASUREMENT DEVICE AND COMPONENT CONCENTRATION MEASUREMENT METHODOctober 2020April 2025Abandon5430NoNo
17064033DEVICE FOR PROCESSING AND VISUALIZING DATA OF AN ELECTRIC IMPEDANCE TOMOGRAPHY APPARATUS FOR DETERMINING AND VISUALIZING REGIONAL VENTILATION DELAYS IN THE LUNGSOctober 2020December 2024Abandon5021YesNo
17044643PRESSURE BASED BLOOD VESSEL ASSESSMENT SYSTEMS AND METHODSOctober 2020August 2024Abandon4610NoNo
17037207CANARY ON A CHIP: EMBEDDED SENSORS WITH BIO-CHEMICAL INTERFACESSeptember 2020May 2025Allow5530NoNo
17033335OCULAR ABERROMETER SYSTEMS AND METHODSSeptember 2020March 2025Allow5440YesYes
17040298HEART FAILURE DEGREE-OF-EXACERBATION DETERMINATION SYSTEM AND HEART FAILURE DEGREE-OF-EXACERBATION DETERMINATION METHODSeptember 2020April 2025Abandon5540YesNo
17019156FEATURE-BASED JOINT RANGE OF MOTION CAPTURING SYSTEM AND RELATED METHODSSeptember 2020August 2024Abandon4720YesNo
17003202Vascular Access Device AdapterAugust 2020October 2025Allow6050YesNo
17001902ON-CHIP INTEGRATED MULTI-WAVELENGTHS BIOLOGICAL SENSING DEVICEAugust 2020June 2024Abandon4520NoNo
16970657OBTAINING IMAGES FOR USE IN DETERMINING ONE OR MORE PROPERTIES OF SKIN OF A SUBJECTAugust 2020February 2025Allow5440YesYes
16970424SENSOR ARRANGEMENT FOR MOUNTING ON A GUIDEWIRE OR CATHETERAugust 2020July 2024Allow4720YesNo
16970244FLEXIBLE CIRCUIT FOR DETECTING LIQUID PRESENCEAugust 2020February 2025Abandon5430NoNo
16989363CATHETER SYSTEM TO FACILITATE BLOOD COLLECTION AND RELATED METHODSAugust 2020March 2024Allow4320YesNo
16930125On-Bed Differential Piezoelectric SensorJuly 2020October 2024Abandon5130YesNo
16959708DETACHABLE VOLUME MEASURING APPARATUS, TISSUE EXPANSION APPARATUS COMPRISING SAME AND BREAST VOLUME MEASURING METHOD USING SAMEJuly 2020March 2024Abandon4501NoNo
16809253NEEDLE STABILIZATION SYSTEM AND METHODS OF USEMarch 2020November 2024Abandon5611NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HOFFPAUIR, ANDREW ELI.

Strategic Value of Filing an Appeal

Total Appeal Filings
5
Allowed After Appeal Filing
4
(80.0%)
Not Allowed After Appeal Filing
1
(20.0%)
Filing Benefit Percentile
95.1%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 80.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner HOFFPAUIR, ANDREW ELI - Prosecution Strategy Guide

Executive Summary

Examiner HOFFPAUIR, ANDREW ELI works in Art Unit 3791 and has examined 66 patent applications in our dataset. With an allowance rate of 37.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 47 months.

Allowance Patterns

Examiner HOFFPAUIR, ANDREW ELI's allowance rate of 37.9% places them in the 6% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by HOFFPAUIR, ANDREW ELI receive 2.23 office actions before reaching final disposition. This places the examiner in the 62% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HOFFPAUIR, ANDREW ELI is 47 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +38.7% benefit to allowance rate for applications examined by HOFFPAUIR, ANDREW ELI. This interview benefit is in the 86% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 25.0% of applications are subsequently allowed. This success rate is in the 39% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 34.6% of cases where such amendments are filed. This entry rate is in the 52% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 66.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 58% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 75% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 50% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.